CIK 0001021561
- Accelerated filer
NU SKIN ENTERPRISES, INC.
Sign in to watch- Ticker
- NUS
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870565309
- Phone
- +1 801-345-1000
- Business address
- 75 WEST CENTER ST, ATTN: GREGORY BELLISTON, PROVO, UT, 84601
- Former names
- NU SKIN ENTERPRISES INC, NU SKIN ASIA PACIFIC INC, NU SKIN ASIA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-07 | CAMPBELL DANIEL W Director | Grant or award | +4,232 | 18,924 | ||
| 2023-06-07 | Battle Emma S. Director | Grant or award | +4,232 | 8,891 | ||
| 2023-06-05 | Hatchett Steven Keith Chief Product Officer | Shares withheld for taxes | −462 | $33.74 | $16K | 57,906 |
| 2023-06-05 | Clark Chayce David EVP and General Counsel | Shares withheld for taxes | −979 | $33.74 | $33K | 100,399 |
| 2023-05-25 | LIPMAN ANDREW D Director | Sale | −2,000 | $34.28 | $69K | 58,393 |
| 2023-05-09 | WOODBURY EDWINA D Director | Sale | −1,255 | $37.87 | $48K | 15,469 |
| 2023-04-25 | LIPMAN ANDREW D Director | Sale | −2,000 | $40.75 | $82K | 60,393 |
| 2023-04-21 | Tang Connie Mang Yee Chief Global Growth Officer | Shares withheld for taxes | −1,120 | $41.37 | $46K | 43,204 |
| 2023-03-31 | Thomas James D Interim CFO | Grant or award | +6,360 | 24,288 | ||
| 2023-03-27 | LIPMAN ANDREW D Director | Sale | −2,000 | $39.29 | $79K | 62,393 |
| 2023-03-13 | Battle Emma S. Director | Other acquisition | +15 | $40.00 | $600 | 7,686 |
| 2023-03-09 | Hatchett Steven Keith Chief Product Officer | Exercise or conversion | +21,155 | $30.45 | $644K | 79,523 |
| 2023-03-09 | Hatchett Steven Keith Chief Product Officer | Sale | −21,155 | $39.78 | $842K | 58,368 |
| 2023-03-09 | Hatchett Steven Keith Chief Product Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −21,155 | 5,602 | ||
| 2023-03-08 | WOODBURY EDWINA D Director | Grant or award | +15 | $39.74 | $596 | 16,724 |
| 2023-03-02 | Lawrence Mark H Chief Financial Officer | Exercise or conversion | +18,041 | $30.45 | $549K | 83,290 |
| 2023-03-02 | Lawrence Mark H Chief Financial Officer | Sale | −26,144 | $40.80 | $1.1M | 57,146 |
| 2023-03-02 | Lawrence Mark H Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −18,041 | 100,000 | ||
| 2023-03-02 | CHANG JOSEPH Y Chief Scientific Officer | Exercise or conversion | +600 | $30.63 | $18K | 21,834 |
| 2023-03-02 | CHANG JOSEPH Y Chief Scientific Officer | Exercise or conversion | +24,400 | $30.45 | $743K | 46,234 |
Page 8 of 15 · 288 trades